- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in the regulation of cholangiocarcinoma growth
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Volume 299, Issue 1, Pages G1-G9
Publisher
American Physiological Society
Online
2010-04-30
DOI
10.1152/ajpgi.00114.2010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vascular factors, angiogenesis and biliary tract disease
- (2010) Shannon S Glaser et al. CURRENT OPINION IN GASTROENTEROLOGY
- Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line
- (2010) Leda Roncoroni et al. LIVER INTERNATIONAL
- Nerve Growth Factor-β Expression Is Associated with Lymph Node Metastasis and Nerve Infiltration in Human Hilar Cholangiocarcinoma
- (2010) Lei-bo Xu et al. WORLD JOURNAL OF SURGERY
- Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
- (2009) D Yoshikawa et al. BRITISH JOURNAL OF CANCER
- Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
- (2009) C Bengala et al. BRITISH JOURNAL OF CANCER
- Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures
- (2009) Chiara Braconi et al. CANCER
- Molecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin
- (2009) P. Pawar et al. CLINICAL CANCER RESEARCH
- Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials
- (2009) John-David Aubert et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2
- (2009) Boris R. A. Blechacz et al. HEPATOLOGY
- Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor
- (2009) Paolo Onori et al. INTERNATIONAL JOURNAL OF CANCER
- Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-κB and induction of apoptosis
- (2009) Paolo Onori et al. INTERNATIONAL JOURNAL OF CANCER
- Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells
- (2009) Molly Lang et al. LIVER INTERNATIONAL
- Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression
- (2009) Giammarco Fava et al. LIVER INTERNATIONAL
- H3 Histamine Receptor-Mediated Activation of Protein Kinase C Inhibits the Growth of Cholangiocarcinoma In vitro and In vivo
- (2009) H. Francis et al. MOLECULAR CANCER RESEARCH
- Biliary Infections: Spectrum of Imaging Findings and Management
- (2009) Onofrio A. Catalano et al. RADIOGRAPHICS
- Transplantation for Cholangiocarcinoma: When and for Whom?
- (2009) David J. Rea et al. Surgical Oncology Clinics of North America
- EGFR and HER2 expression in advanced biliary tract cancer
- (2009) Jan Harder et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway
- (2008) Sharon DeMorrow et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Serotonin Metabolism Is Dysregulated in Cholangiocarcinoma, which Has Implications for Tumor Growth
- (2008) G. Alpini et al. CANCER RESEARCH
- Leptin Enhances Cholangiocarcinoma Cell Growth
- (2008) G. Fava et al. CANCER RESEARCH
- Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth
- (2008) M. Marzioni et al. DIGESTIVE AND LIVER DISEASE
- Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor
- (2008) A. Mancino et al. DIGESTIVE AND LIVER DISEASE
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice
- (2008) M. Demestre et al. PHYTOTHERAPY RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started